On 2025-11-14, GRI Bio, Inc. (GRI) announced earnings per share of $-35.85 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-31.09.
The next expected annoucement date for quarterly earnings is 2026-05-21, with an average estimated earnings per share of $-19.89 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-11-14 | 2025-09-30 | $-31.09 | $-35.85 |
| 2025-08-14 | 2025-06-30 | $-36.69 | $-36.69 |
| 2025-05-15 | 2025-03-31 | -- | $-162.46 |
| 2024-11-14 | 2024-09-30 | -- | $-319.18 |
| 2024-08-13 | 2024-06-30 | -- | $-2343.79 |
| 2024-05-10 | 2024-03-31 | -- | $-2849.61 |
| 2023-11-14 | 2023-09-30 | -- | $-22542.35 |
| 2023-08-14 | 2023-06-30 | -- | $-120948.38 |
| 2023-05-15 | 2023-03-31 | -- | $-231059.09 |
| 2023-02-24 | 2022-12-31 | -- | $-130182.20 |
| 2022-11-03 | 2022-09-30 | $-325455.50 | $-156218.64 |
| 2022-07-28 | 2022-06-30 | $-299419.06 | $-260364.41 |
| 2022-05-09 | 2022-03-31 | $-286400.84 | $-507710.56 |
| 2022-02-14 | 2021-12-31 | $-286400.84 | $-598838.13 |
| 2021-11-12 | 2021-09-30 | -- | $-234327.97 |
| 2021-08-10 | 2021-06-30 | -- | $-442619.50 |
| 2021-05-13 | 2021-03-31 | -- | $-598838.13 |